Thomas S. Harrison

Active 1997–2025

Also published as
Thomas S Harrison
99
Papers
19,749
Citations
65
h-index
95
i10-index

Citations

Citations per year for Thomas S. Harrison1990: 1 citations1996: 1 citations1998: 1 citations1999: 1 citations2000: 9 citations2001: 7 citations2002: 4 citations2003: 5 citations2004: 9 citations2005: 17 citations2006: 22 citations2007: 30 citations2008: 51 citations2009: 63 citations2010: 106 citations2011: 58 citations2012: 122 citations2013: 190 citations2014: 133 citations2015: 160 citations2016: 151 citations2017: 132 citations2018: 149 citations2019: 527 citations2020: 599 citations2021: 598 citations2022: 549 citations2023: 479 citations2024: 920 citations2025: 367 citations2026: 5 citations1991–1995: no citations, so these years are not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,368 citing papers, 20.3% of this breakdownUnited Kingdom: 582 citing papers, 8.7% of this breakdownChina: 511 citing papers, 7.6% of this breakdownFrance: 308 citing papers, 4.6% of this breakdownBrazil: 251 citing papers, 3.7% of this breakdownGermany: 245 citing papers, 3.6% of this breakdownSouth Africa: 218 citing papers, 3.2% of this breakdownAustralia: 205 citing papers, 3.1% of this breakdownNetherlands: 202 citing papers, 3% of this breakdownCanada: 194 citing papers, 2.9% of this breakdownIndia: 190 citing papers, 2.8% of this breakdownSpain: 186 citing papers, 2.8% of this breakdown
0%20.3%Other 33.7%

Fields

  • Medicine83.7%
  • Biochemistry, Genetics and Molecular Biology6.1%
  • Immunology and Microbiology4%
  • Agricultural and Biological Sciences1.4%
  • Environmental Science0.8%
  • Chemistry0.7%
  • Other3.3%

Topics

  • Antifungal resistance and susceptibility20.1%
  • Fungal Infections and Studies19.6%
  • Nail Diseases and Treatments6.4%
  • Pneumocystis jirovecii pneumonia detection and treatment3.2%
  • Plant Pathogens and Fungal Diseases2.6%
  • Tuberculosis Research and Epidemiology2.3%
  • Other45.8%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. Tackling the emerging threat of antifungal resistance to human health

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Reviews Microbiology 2022 cited by 1,116

  3. The importance of antimicrobial resistance in medical mycology

    Authors: , , , , , , , , , , , - Nature Communications 2022 cited by 219

  4. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erik van Widenfelt, Tao Chen, Duolao Wang, William Hope, Timothée Boyer‐Chammard, Angela Loyse, Síle F. Molloy, Nabila Youssouf, Olivier Lortholary, David G. Lalloo, Shabbar Jaffar, Thomas S. Harrison - New England Journal of Medicine 2022 cited by 269

  5. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 2,665

  6. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégory Jouvion, David B. Meya, David S. Lawrence, Sebastian Rahn, Felix Bongomin, Brendan McMullan, Rosanne Sprute, Tinashe K. Nyazika, Justin Beardsley, Fabianne Carlesse, Christopher H. Heath, Olusola Ayanlowo, Olga Mashedi, Flávio Queiróz-Telles Filho, Mina C. Hosseinipour, Atul Patel, Elvis Temfack, Nina Singh, Oliver A. Cornely, David R. Boulware, Olivier Lortholary, Peter G. Pappas, John R. Perfect - The Lancet Infectious Diseases 2024 cited by 269

  7. Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amanathan Kirthivasan, Anwar Ijaz, Kirsty Harkness, Sevasti Ispoglou, Nigel Smyth, Aravinth Sivagnanaratnam, David Cohen, Lakshmanan Sekaran, Dinesh Chadha, Nasar Ahmad, Pratap Rana, Malik Azhar Hussain, Nic Weir, Thomas S. Harrison, Salim Elyas - JAMA Neurology 2023 cited by 128

  8. Fungal infections in HIV/AIDS

    Authors: , , , - The Lancet Infectious Diseases 2017 cited by 483

  9. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tihana Bicanic, David G. Lalloo, Duolao Wang, Mina C. Hosseinipour, Olivier Lortholary, Shabbar Jaffar, Thomas S. Harrison - New England Journal of Medicine 2018 cited by 405

  10. The pathobiology of human fungal infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Microbiology 2024 cited by 133

  11. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 168

  12. The Cryptococcus neoformans Titan cell is an inducible and regulated morphotype underlying pathogenesis

    Authors: , , , , , , , , , , , , , , , , - PLoS Pathogens 2018 cited by 194

  13. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy

    Authors: , , , , , , - Nature Reviews Neurology 2016 cited by 489

  14. Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2013 cited by 371

  15. High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 444

  16. Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis

    Authors: , , , , , , , , , - AIDS 2012 cited by 286

  17. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance

    Authors: , , , , , , , , , , , , , , - mBio 2019 cited by 70

  18. Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Imran Ahmed, Rumina Hasan, Marcos Burgos, Faisal Sultan, Mariam Hassan, Iqra Masood, Claire Robb, Jonathan Decker, Sisa Grubnic, Philip D. Butcher, Adam A. Witney, Jasvir Dhillon, Tulika Munshi, Katherine Fielding, Thomas S. Harrison - NEJM Evidence 2023 cited by 30

  19. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal

    Authors: , , , , - Journal of Antimicrobial Chemotherapy 2013 cited by 159

  20. Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 114

  21. Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome

    Authors: , , , , , , , , , , , , , , , , , , , - mBio 2022 cited by 45

  22. Cryptococcal meningoencephalitis: time for action

    Authors: , , , , , , , , , , - The Lancet Infectious Diseases 2021 cited by 57

  23. Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris In Vitro

    Authors: , , , , , , - Antimicrobial Agents and Chemotherapy 2023 cited by 29

  24. Advances in the diagnosis and treatment of fungal infections of the CNS

    Authors: , , , - The Lancet Neurology 2018 cited by 135